Stay updated on Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial page.

Latest updates to the Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check45 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a revision in the content. The phrase 'Here’s how you know' has been removed and replaced with the same phrase, suggesting a possible formatting or presentation change rather than a substantive content update.SummaryDifference1.0%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check96 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check110 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
Stay in the know with updates to Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial page.